Beyond its role in atherosclerosis, PCSK9 enhances platelet reactivity by upregulating lipid‐mediated signaling pathways, thereby increasing blood hypercoagulability and thrombosis susceptibility [72]. Here, PCSK9 is linked to atherosclerosis.